Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q2 EPS of ($0.48), $0.01 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $3.76 million versus the consensus estimate of $3.07 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.